{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:35:32Z","timestamp":1790724932591,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Israel Science Foundation (ISF)-Centers of Excellence"},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["294390 PICHO"],"award-info":[{"award-number":["294390 PICHO"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["281738 LIVERMICROENV"],"award-info":[{"award-number":["281738 LIVERMICROENV"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Israel Cancer Research Fund Professorship"},{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"crossref","award":["NIH P30 CA008748"],"award-info":[{"award-number":["NIH P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cell.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T10:40:42Z","timestamp":1535020842000},"page":"171-185.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Small Molecules Co-targeting CKI\u03b1 and the Transcriptional Kinases CDK7\/9 Control AML in Preclinical Models"],"prefix":"10.1016","volume":"175","author":[{"given":"Waleed","family":"Minzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanthika","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brachya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Burstain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Shaham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitai","family":"Rivlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adar","family":"Zinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Erdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dansu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathali","family":"Kaushansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Shlush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Pikarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Snir-Alkalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinon","family":"Ben-Neriah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2018.07.045_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1101\/gad.230302","article-title":"Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway","volume":"16","author":"Amit","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2018.07.045_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barab\u00e9","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cell.2018.07.045_bib4","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/bloodadvances.2017008227","article-title":"Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis","volume":"1","author":"Boddu","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.cell.2018.07.045_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib6","doi-asserted-by":"crossref","first-page":"E8035","DOI":"10.1073\/pnas.1702763114","article-title":"CK1\u03b1 ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation","volume":"114","author":"Chang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2018.07.045_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ng1572","article-title":"Temporal dissection of p53 function in\u00a0vitro and in\u00a0vivo","volume":"37","author":"Christophorou","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2018.07.045_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrclinonc.2015.210","article-title":"Molecular therapy for acute myeloid leukaemia","volume":"13","author":"Coombs","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2018.07.045_bib9","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/emboj\/18.11.3054","article-title":"Excess beta-catenin promotes accumulation of transcriptionally active p53","volume":"18","author":"Damalas","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2018.07.045_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2015-08-604520","article-title":"An update of current treatments for adult acute myeloid leukemia","volume":"127","author":"Dombret","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cell.2018.07.045_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature09673","article-title":"CKI\u03b1 ablation highlights a critical role for p53 in invasiveness control","volume":"470","author":"Elyada","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A\u00a0small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2018.07.045_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2018.07.045_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1101\/gad.309351.117","article-title":"Widespread transcriptional pausing and elongation control at enhancers","volume":"32","author":"Henriques","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2018.07.045_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.20131033","article-title":"Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia","volume":"211","author":"J\u00e4r\u00e5s","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2018.07.045_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nature09526","article-title":"Selective activation of p53-mediated tumour suppression in high-grade tumours","volume":"468","author":"Junttila","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib19","doi-asserted-by":"crossref","first-page":"eaan4368","DOI":"10.1126\/science.aan4368","article-title":"The target landscape of clinical kinase drugs","volume":"358","author":"Klaeger","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2018.07.045_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.chembiol.2005.04.011","article-title":"Features of selective kinase inhibitors","volume":"12","author":"Knight","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cell.2018.07.045_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fonc.2014.00096","article-title":"The CK1 family: contribution to cellular stress response and its role in carcinogenesis","volume":"4","author":"Knippschild","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cell.2018.07.045_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.exphem.2016.05.014","article-title":"Pharmacological activation of wild-type p53 in the therapy of leukemia","volume":"44","author":"Kojima","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.cell.2018.07.045_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.cell.2018.07.045_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2018.07.045_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"L\u00f6wenberg","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2018.07.045_bib30","doi-asserted-by":"crossref","first-page":"e06535","DOI":"10.7554\/eLife.06535","article-title":"Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism","volume":"4","author":"Lu","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.cell.2018.07.045_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0174-3","article-title":"Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II","volume":"558","author":"Lu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib32","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1073\/pnas.1604765113","article-title":"Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity","volume":"113","author":"Nakagawa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2018.07.045_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ni.3517","article-title":"Emerging concepts of epigenetic dysregulation in hematological malignancies","volume":"17","author":"Ntziachristos","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2018.07.045_bib34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2018.07.045_bib49","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1172\/JCI78440","article-title":"Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program","volume":"125","author":"Park","year":"2015","journal-title":"J Clin. Invest."},{"key":"10.1016\/j.cell.2018.07.045_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccr.2013.06.005","article-title":"A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism","volume":"24","author":"Pribluda","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aam7340","article-title":"Waste disposal-an attractive strategy for cancer therapy","volume":"355","author":"Salami","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2018.07.045_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccr.2014.08.001","article-title":"Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS","volume":"26","author":"Schneider","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.blre.2016.02.001","article-title":"Update on rational targeted therapy in AML","volume":"30","author":"Shafer","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/j.cell.2018.07.045_bib40","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccell.2015.03.009","article-title":"Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia","volume":"27","author":"Shih","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib42","article-title":"DiffBind: differential binding analysis of ChIP-Seq peak data","volume":"100","author":"Stark","year":"2011","journal-title":"R package version"},{"key":"10.1016\/j.cell.2018.07.045_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cell.2018.07.045_bib44","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","article-title":"Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies","volume":"50","author":"Widmer","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cell.2018.07.045_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPO58YWIBUBESX","article-title":"Extramedullary manifestations of myeloid neoplasms","volume":"144","author":"Wilson","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cell.2018.07.045_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","article-title":"BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment","volume":"67","author":"Winter","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2018.07.045_bib47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nsmb.3285","article-title":"The pol II CTD: new twists in the tail","volume":"23","author":"Zaborowska","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2018.07.045_bib48","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418309735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867418309735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:04:12Z","timestamp":1568934252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867418309735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0092867418309735"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2018.07.045","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Molecules Co-targeting CKI\u03b1 and the Transcriptional Kinases CDK7\/9 Control AML in Preclinical Models","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}